Team-based learning course
The International Society on Thrombosis and Haemostasis (ISTH) has launched a new team-based learning course focused on bringing together early-career physicians from around the world to collaborate on complex cases in bleeding and clotting.
The course features three case modules on these topics:
- Cancer-associated thrombosis
- Congenital hemophilia with inhibitors
- Treatment duration in patient with recurrent thrombosis and high bleeding risk
The course will accommodate three learning teams, each consisting of up to seven students (15-21 total students) and two facilitators (six total facilitators), who will mentor the students. The virtual course lasts 14 weeks, March 25-June 28, with a final in-person meeting in Montréal, Canada, at the ISTH 2023 Congress (virtual attendance also available). Learning teams will meet virtually at least once weekly, with a gap week between each module.
Course learning objectives
By the end of the course, the participants will be able to:
- Manage parenteral and oral anticoagulation treatment of cancer-associated thrombosis in settings of malignancies with high bleeding risk
- Design a treatment plan, including immunotolerance, in patients with congenital hemophilia with inhibitors
- Make evidence-based decisions on treatment type and duration in patients with recurrent thrombosis and concomitant high risk for bleeding.
Facilitators
Facilitators will act as mentors to the learning teams, providing guidance and steering learning to ensure productive and rewarding experiences for everyone. Facilitators will meet with students virtually to help work through cases, and attend the final meeting at ISTH 2023 in Montreal.
Facilitators should be specialist physicians with five to seven years of experience managing bleeding and/or thrombotic disorders. Facilitators will receive a certificate at the completion of the course.